Literature DB >> 26684955

Percutaneous microembolization of the left coronary artery to model ischemic heart disease in rats.

Allard Wagenaar1, Rob F Wiegerinck1, Viviane V T Heijnen1, Mark J Post1.   

Abstract

Small animal models of myocardial infarction are used for a wide variety of research purposes, but common techniques for generating such models require thoracic surgeries that increase mortality risk and damage important structures, such as the pericardial sac. Here, we describe a technique for modeling myocardial infarction in rats by selective coronary microembolization, which has hitherto been described only in large animals. This technique selectively catheterizes the left coronary artery using a custom-made catheter that is introduced and precisely placed under fluoroscopic guidance. Microspheres are then injected through the catheter to cause embolization. This process creates multiple simultaneous micro-infarcts that resemble those from clinical embolization after a percutaneous coronary intervention. As this technique does not require thoracic surgery, a low attrition rate was expected and once it was optimized, this technique had a low mortality rate of just 14% during experimental application. This technique creates infarcts that appear small but are associated with transient ECG changes and a persistently lower ejection fraction after embolization. Microspheres are retained in the myocardial tissue and are visible by epifluorescent microscopy after histological staining and recognizable as a distinct speckle pattern in ultrasound images.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26684955     DOI: 10.1038/laban.909

Source DB:  PubMed          Journal:  Lab Anim (NY)        ISSN: 0093-7355            Impact factor:   12.625


  16 in total

Review 1.  Delivery strategies to achieve therapeutic myocardial angiogenesis.

Authors:  R Kornowski; S Fuchs; M B Leon; S E Epstein
Journal:  Circulation       Date:  2000-02-01       Impact factor: 29.690

2.  Intrapericardial delivery enhances cardiac effects of sotalol and atenolol.

Authors:  Thomas J van Brakel; J J Rob Hermans; Ben J Janssen; Helma van Essen; Nicole Botterhuis; Jos F M Smits; Jos G Maessen
Journal:  J Cardiovasc Pharmacol       Date:  2004-07       Impact factor: 3.105

3.  Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine.

Authors:  M Arras; R Strasser; M Mohri; R Doll; P Eckert; W Schaper; J Schaper
Journal:  Basic Res Cardiol       Date:  1998-04       Impact factor: 17.165

4.  Simple method to produce acute heart failure by coronary vessel embolization in closed chest rats with microspheres.

Authors:  E A Gorodetskaya; S F Dugin; O S Medvedev; A E Allabergenova
Journal:  J Pharmacol Methods       Date:  1990-08

Review 5.  Ischemia, reperfusion, and the determinants of tissue injury.

Authors:  D J Hearse
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 6.  Coronary microembolization.

Authors:  Gerd Heusch; Rainer Schulz; Michael Haude; Raimund Erbel
Journal:  J Mol Cell Cardiol       Date:  2004-07       Impact factor: 5.000

7.  Role of androgens in sex differences in cardiac damage during myocardial infarction.

Authors:  Thi Y L Le; Anthony W Ashton; Mahidi Mardini; Peter G Stanton; John W Funder; David J Handelsman; Anastasia S Mihailidou
Journal:  Endocrinology       Date:  2013-12-11       Impact factor: 4.736

8.  Role of adenosine in hyperemic response of coronary blood flow in microembolization.

Authors:  M Hori; M Inoue; M Kitakaze; Y Koretsune; K Iwai; J Tamai; H Ito; A Kitabatake; T Sato; T Kamada
Journal:  Am J Physiol       Date:  1986-03

9.  Experimental myocardial infarction in the closed-chest dog: a new technique.

Authors:  C Zollikofer; W Castaneda-Zuniga; Z Vlodaver; J Rysavy; A S Gomes; K Amplatz
Journal:  Invest Radiol       Date:  1981 Jan-Feb       Impact factor: 6.016

10.  Selective coronary embolization in closed-chest dogs.

Authors:  R W Chagrasulis; J M Downey
Journal:  Am J Physiol       Date:  1977-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.